AAAAAA
Results:
1-7
|
Results: 7
Authors:
PAWLIK CA
ISRAEL M
SWEATMAN TW
LOTHSTEIN L
Citation: Ca. Pawlik et al., CELLULAR-RESISTANCE AGAINST THE NOVEL HYBRID ANTHRACYCLINE N-(2-CHLOROETHYL)-N-NITROSOUREIDODAUNORUBICIN (AD-312) IS MEDIATED BY COMBINED ALTERED TOPOISOMERASE-II AND O-6-METHYLGUANINE-DNA METHYLTRANSFERASE ACTIVITIES, Oncology research, 10(4), 1998, pp. 209-217
Authors:
LOTHSTEIN L
RODRIGUES PJ
SWEATMAN TW
ISRAEL M
Citation: L. Lothstein et al., CYTOTOXICITY AND INTRACELLULAR BIOTRANSFORMATION OF N-BENZYLADRIAMYCIN-14-VALERATE (AD-198) ARE MODULATED BY CHANGES IN 14-O-ACYL CHAIN-LENGTH, Anti-cancer drugs, 9(1), 1998, pp. 58-66
Authors:
LAMPIDIS TJ
KOLONIAS D
PODONA T
ISRAEL M
SAFA AR
LOTHSTEIN L
SAVARAJ N
TAPIERO H
PRIEBE W
Citation: Tj. Lampidis et al., CIRCUMVENTION OF P-GP MDR AS A FUNCTION OF ANTHRACYCLINE LIPOPHILICITY AND CHARGE, Biochemistry, 36(9), 1997, pp. 2679-2685
Authors:
DORNELAS EA
CORRELL RE
LOTHSTEIN L
WILBER C
GOETHE JW
Citation: Ea. Dornelas et al., DESIGNING AND IMPLEMENTING OUTCOME EVALUATIONS - SOME GUIDELINES FOR PRACTITIONERS, Psychotherapy, 33(2), 1996, pp. 237-245
Authors:
LOTHSTEIN L
SWEATMAN TW
PRIEBE W
Citation: L. Lothstein et al., HYDROXYLATION AT C-3' OF DOXORUBICIN ALTERS THE SELECTED PHENOTYPE OFCELLULAR-DRUG RESISTANCE, Bioorganic & medicinal chemistry letters, 5(16), 1995, pp. 1807-1812
Authors:
LOTHSTEIN L
KOSEKI Y
SWEATMAN TW
Citation: L. Lothstein et al., P-GLYCOPROTEIN OVEREXPRESSION IN MOUSE CELLS DOES NOT CORRELATE WITH RESISTANCE TO N-BENZYLADRIAMYCIN-14-VALERATE (AD-198), Anti-cancer drugs, 5(6), 1994, pp. 623-633
Authors:
LOTHSTEIN L
HOSEY LM
SWEATMAN TW
KOSEKI Y
DOCKTER M
PRIEBE W
Citation: L. Lothstein et al., N-BENZYLADRIAMYCIN-14-VALERATE (AD-198)-RESISTANT CELLS EXHIBIT HIGHLY SELECTIVE CROSS-RESISTANCE TO OTHER ANTHRACYCLINES THAT CIRCUMVENT MULTIDRUG-RESISTANCE, Oncology research, 5(6-7), 1993, pp. 229-234
Risultati:
1-7
|